This announcement is a separate document:
特一药业：东莞证券股份有限公司关于特一药业集团股份有限公司2023年度以简易程序向特定对象发行股票限售股份上市流通的核查意见
Teyi Pharmaceutical: Dongguan Securities Co., Ltd.\'s inspection opinions on the issuance of shares to specific targets by Teyi Pharmaceutical Group Co., Ltd. in 2023 through simple procedures to limit the listing and circulation of shares
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.